documents: FDA-2014-N-0002-0064

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-N-0002-0064 FDA FDA-2014-N-0002 Finding of No Significant Impact (FONSI) in support of a supplemental New Animal Drug Application for SYNOVEX CHOICE (estradiol benzoate and trenbolone acetate implant) re New Animal Drugs; Alfaxalone; Dinoprost; Ivermectin and Clorsulon; Nitrofurazone; Trenbolone and Estradiol Benzoate; Trimethoprim and Sulfadiazine; Tylosin; Change of Sponsor Supporting & Related Material Background Material 2014-10-28T04:00:00Z 2014 10     2014-10-28T17:15:36Z   0 0 0900006481901c35

Links from other tables